Cumberland Pharmaceuticals (CPIX) Gross Profit (2016 - 2025)
Historic Gross Profit for Cumberland Pharmaceuticals (CPIX) over the last 17 years, with Q3 2025 value amounting to $3.9 million.
- Cumberland Pharmaceuticals' Gross Profit fell 1769.95% to $3.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $24.2 million, marking a year-over-year increase of 2569.78%. This contributed to the annual value of $20.8 million for FY2024, which is 121.24% down from last year.
- As of Q3 2025, Cumberland Pharmaceuticals' Gross Profit stood at $3.9 million, which was down 1769.95% from $6.6 million recorded in Q2 2025.
- Cumberland Pharmaceuticals' 5-year Gross Profit high stood at $7.5 million for Q1 2025, and its period low was $3.9 million during Q3 2025.
- Its 5-year average for Gross Profit is $5.6 million, with a median of $5.6 million in 2024.
- In the last 5 years, Cumberland Pharmaceuticals' Gross Profit plummeted by 2683.8% in 2023 and then soared by 7225.14% in 2025.
- Cumberland Pharmaceuticals' Gross Profit (Quarter) stood at $5.0 million in 2021, then grew by 14.57% to $5.7 million in 2022, then decreased by 20.03% to $4.6 million in 2023, then skyrocketed by 35.25% to $6.2 million in 2024, then crashed by 37.9% to $3.9 million in 2025.
- Its Gross Profit was $3.9 million in Q3 2025, compared to $6.6 million in Q2 2025 and $7.5 million in Q1 2025.